STATE OF PLAY

When a widely used medical treatment became the subject of public scrutiny driven by conspiracy theories and misinformation, the resulting backlash quickly escalated into intense congressional oversight and targeted political pressure. Subsequently, a major drug manufacturer was placed in the crosshairs of public and governmental scrutiny, driving a significant 45% decrease in its stock price. 

ACTION

Narrative implemented a strategic approach to address this multifaceted challenge to monitor, analyze, and counteract misinformation while equipping the company to respond effectively to its detractors. 

 Proactive Media Monitoring & Analysis – Narrative facilitated real-time monitoring of media and stakeholders, keeping the client updated on the activities of relevant activists and elected officials across social and traditional platforms. Identifying emerging threats like committee hearings and press interviews involving key stakeholders helped Narrative provide actionable insights that informed the company’s response.  

Strategic Collateral Deployment – Narrative, using intelligence from monitoring efforts, developed research-based messaging collateral aimed at addressing misinformation at its source and engaged select media outlets with well-timed, strategic storylines to counter detractors.  

Coordinated Message Alignment – Narrative worked closely with the company’s communications, government relations, legal, and security teams to ensure seamless message delivery across leadership, enabling a unified and proactive response.   

IMPACT

While the immediate threat has subsided, Narrative continues to support the company in navigating ongoing challenges by shaping effective messaging and positioning them to respond decisively at critical moments.